Decision letter for "CD96 functions as a co‐stimulatory receptor to enhance CD8 <sup>+</sup> T cell activation and effector responses"

Decision letter for "Essential role of IκB NS for in vivo CD4 + T cell activation, proliferation and Th1 cell differentiation during Listeria monocytogenes infection in mice"

10.1002/eji.201847961/v1/decision1 ◽

2018 ◽

Keyword(s):

Cell Differentiation ◽

Listeria Monocytogenes ◽

T Cell ◽

T Cell Activation ◽

Essential Role ◽

Cell Activation ◽

Th1 Cell

Review for "CD96 functions as a co‐stimulatory receptor to enhance CD8 + T cell activation and effector responses"

10.1002/eji.201948405/v2/review1 ◽

2019 ◽

Keyword(s):

T Cell ◽

T Cell Activation ◽

Cell Activation

Decision letter for "MiR‐181a regulates CD4 + T cell activation and differentiation by targeting IL‐2 in the pathogenesis of myasthenia gravis"

10.1002/eji.201848007/v3/decision1 ◽

2019 ◽

Keyword(s):

T Cell ◽

Myasthenia Gravis ◽

T Cell Activation ◽

Cell Activation

Review for "MiR‐181a regulates CD4 + T cell activation and differentiation by targeting IL‐2 in the pathogenesis of myasthenia gravis"

10.1002/eji.201848007/v2/review1 ◽

2019 ◽

Author(s):

Henry Kaminski

Keyword(s):

T Cell ◽

Myasthenia Gravis ◽

T Cell Activation ◽

Cell Activation

Decision letter for "MiR‐181a regulates CD4 + T cell activation and differentiation by targeting IL‐2 in the pathogenesis of myasthenia gravis"

10.1002/eji.201848007/v2/decision1 ◽

2019 ◽

Keyword(s):

T Cell ◽

Myasthenia Gravis ◽

T Cell Activation ◽

Cell Activation

Review for "Tumor necrosis factor receptor family co‐stimulation increases regulatory T cell activation and function via NF‐κB"

10.1002/eji.201948393/v1/review1 ◽

2019 ◽

Keyword(s):

T Cell ◽

Tumor Necrosis Factor ◽

T Cell Activation ◽

Regulatory T Cell ◽

Tumor Necrosis ◽

Cell Activation ◽

Tumor Necrosis Factor Receptor ◽

And Function ◽

Necrosis Factor ◽

Receptor Family

Review for "CD5 blockade enhances ex vivo CD8 + T cell activation and tumour cell cytotoxicity"

10.1002/eji.201948309/v2/review1 ◽

2019 ◽

Keyword(s):

T Cell ◽

T Cell Activation ◽

Tumour Cell ◽

Cell Activation ◽

Ex Vivo ◽

Cell Cytotoxicity

CTLA-4 interferes with T cell activation by blocking TCR-induced ERK and JNK activity

Immunology Letters ◽

10.1016/s0165-2478(97)87098-8 ◽

1997 ◽

Vol 56 (1-3) ◽

pp. 68

Author(s):

C Calvo

Keyword(s):

T Cell ◽

T Cell Activation ◽

Cell Activation

Treatment with monoclonal antibodies (mAbs) against the 4-1BB T-cell activation molecule eradicate established tumors

Immunology Letters ◽

10.1016/s0165-2478(97)88301-0 ◽

1997 ◽

Vol 56 (1-3) ◽

pp. 362 ◽

Cited By ~ 1

Author(s):

I Melero

Keyword(s):

Monoclonal Antibodies ◽

T Cell ◽

T Cell Activation ◽

Cell Activation

The role of CD80 and CD86 in Mycobacterial antigen induced T cell activation

Immunology Letters ◽

10.1016/s0165-2478(97)88294-6 ◽

1997 ◽

Vol 56 (1-3) ◽

pp. 360

Author(s):

R De Jong

Keyword(s):

T Cell ◽

T Cell Activation ◽

Cell Activation ◽

Mycobacterial Antigen

Decision letter for "CD96 functions as a co‐stimulatory receptor to enhance CD8 + T cell activation and effector responses"

Decision letter for "Essential role of IκB NS for in vivo CD4 + T cell activation, proliferation and Th1 cell differentiation during Listeria monocytogenes infection in mice"

Review for "CD96 functions as a co‐stimulatory receptor to enhance CD8 + T cell activation and effector responses"

Decision letter for "MiR‐181a regulates CD4 + T cell activation and differentiation by targeting IL‐2 in the pathogenesis of myasthenia gravis"

Review for "MiR‐181a regulates CD4 + T cell activation and differentiation by targeting IL‐2 in the pathogenesis of myasthenia gravis"

Decision letter for "MiR‐181a regulates CD4 + T cell activation and differentiation by targeting IL‐2 in the pathogenesis of myasthenia gravis"

Review for "Tumor necrosis factor receptor family co‐stimulation increases regulatory T cell activation and function via NF‐κB"

Review for "CD5 blockade enhances ex vivo CD8 + T cell activation and tumour cell cytotoxicity"

CTLA-4 interferes with T cell activation by blocking TCR-induced ERK and JNK activity

Treatment with monoclonal antibodies (mAbs) against the 4-1BB T-cell activation molecule eradicate established tumors

The role of CD80 and CD86 in Mycobacterial antigen induced T cell activation

Export Citation Format